{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:11:46Z","timestamp":1779927106328,"version":"3.53.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["26460101"],"award-info":[{"award-number":["26460101"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"JSPS","doi-asserted-by":"publisher","award":["16K21311"],"award-info":[{"award-number":["16K21311"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["S1511001L"],"award-info":[{"award-number":["S1511001L"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.npep.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T07:17:35Z","timestamp":1495523855000},"page":"71-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Inhibitory effect of angiotensin (1-7) on angiotensin III-induced nociceptive behaviour in mice"],"prefix":"10.1016","volume":"65","author":[{"given":"Wataru","family":"Nemoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Yamagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Ogata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Nakagawasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Tadano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tan-No","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2017.05.002_bb0005","first-page":"H313","article-title":"Antihypertensive actions of angiotensin-(1-7) in spontaneously hypertensive rats","volume":"269","author":"Benter","year":"1995","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.npep.2017.05.002_bb0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/CS20110036","article-title":"Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors","volume":"121","author":"Bosnyak","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"key":"10.1016\/j.npep.2017.05.002_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030338","article-title":"Regulation of peripheral inflammation by spinal p38 MAP kinase in rats","volume":"3","author":"Boyle","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.npep.2017.05.002_bb0020","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.npep.2015.10.003","article-title":"Brain angiotensin-(1-7)\/Mas axis: a new target to reduce the cardiovascular risk to emotional stress","volume":"56","author":"Fontes","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.05.002_bb0025","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1097\/j.pain.0000000000000690","article-title":"Angiotensin-(1-7)\/Mas receptor as an antinociceptive agent in cancer-induced bone pain","volume":"157","author":"Forte","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.npep.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1590\/S1807-59322011000500021","article-title":"An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect","volume":"66","author":"Fraga-Silva","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.npep.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0304-3940(76)90020-3","article-title":"Immunohistochemical evidence for the existence of angiotensin II-containing nerve terminals in the brain and spinal cord in the rat","volume":"2","author":"Fuxe","year":"1976","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.05.002_bb0040","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/HYPERTENSIONAHA.116.08118","article-title":"Cardioprotective angiotensin-(1-7) peptide acts as a natural-biased ligand at the angiotensin II type 1 receptor","volume":"68","author":"Galandrin","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.npep.2017.05.002_bb0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S0031-6997(24)01458-3","article-title":"International union of pharmacology. XXIII. The angiotensin II receptors","volume":"52","author":"de Gasparo","year":"2000","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.npep.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2007.11.065","article-title":"Attenuating phosphorylation of p38 MAPK in the activated microglia: a new mechanism for intrathecal lidocaine reversing tactile allodynia following chronic constriction injury in rats","volume":"431","author":"Gu","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.05.002_bb0055","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(80)90515-4","article-title":"Intrathecal morphine in mice: a new technique","volume":"67","author":"Hylden","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2017.05.002_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.npep.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","article-title":"G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor","volume":"111","author":"Kostenis","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2017.05.002_bb0070","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/jnc.13386","article-title":"Direct anti-inflammatory effects of angiotensin-(1-7) on microglia","volume":"136","author":"Liu","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2017.05.002_bb0075","doi-asserted-by":"crossref","first-page":"H1116","DOI":"10.1152\/ajpheart.00832.2011","article-title":"Angiotensin-(1-7) attenuates the chronotropic response to angiotensin II via stimulation of PTEN in the spontaneously hypertensive rat neurons","volume":"302","author":"Modgil","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.npep.2017.05.002_bb0080","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1744-8069-9-38","article-title":"Angiotensin II produces nociceptive behavior through spinal AT1 receptor-mediated p38 mitogen-activated protein kinase activation in mice","volume":"9","author":"Nemoto","year":"2013","journal-title":"Mol. Pain"},{"key":"10.1016\/j.npep.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.npep.2012.11.002","article-title":"Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice","volume":"47","author":"Nemoto","year":"2013","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2017.05.002_bb0090","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/ejp.512","article-title":"Angiotensin (1-7) prevents angiotensin II-induced nociceptive behaviour via inhibition of p38 MAPK phosphorylation mediated through spinal Mas receptors in mice","volume":"18","author":"Nemoto","year":"2014","journal-title":"Eur. J. Pain"},{"key":"10.1016\/j.npep.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.neuropharm.2015.07.022","article-title":"Involvement of p38 MAPK activation mediated through AT1 receptors on spinal astrocytes and neurons in angiotensin II- and III-induced nociceptive behavior in mice","volume":"99","author":"Nemoto","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neulet.2014.11.018","article-title":"The intrathecal administration of losartan, an AT1 receptor antagonist, produces an antinociceptive effect through the inhibition of p38 MAPK phosphorylation in the mouse formalin test","volume":"585","author":"Nemoto","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.npep.2017.05.002_bb0105","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jphs.2016.07.009","article-title":"Chondroitin sulfate attenuates formalin-induced persistent tactile allodynia","volume":"131","author":"Nemoto","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.npep.2017.05.002_bb0110","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1124\/mol.116.104133","article-title":"Involvement of spinal angiotensin II system in streptozotocin-induced diabetic neuropathic pain in mice","volume":"90","author":"Ogata","year":"2016","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.npep.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.regpep.2010.03.004","article-title":"Intraneuronal angiotensinergic system in rat and human dorsal root ganglia","volume":"162","author":"Patil","year":"2010","journal-title":"Regul. Pept."},{"key":"10.1016\/j.npep.2017.05.002_bb0120","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin-angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2017.05.002_bb0125","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuropharm.2013.03.025","article-title":"Anti-inflammatory effects of angiotensin-(1-7) in ischemic stroke","volume":"71","author":"Regenhardt","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2017.05.002_bb0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1113\/expphysiol.2008.042002","article-title":"Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis","volume":"93","author":"Santos","year":"2008","journal-title":"Exp. Physiol."},{"key":"10.1016\/j.npep.2017.05.002_bb0135","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1046\/j.1471-4159.2003.01969.x","article-title":"Activation of p38 mitogen-activated protein kinase in spinal microglia is a critical link in inflammation-induced spinal pain processing","volume":"86","author":"Svensson","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.npep.2017.05.002_bb0140","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","article-title":"Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice","volume":"30","author":"Tesanovic","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.npep.2017.05.002_bb0145","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/glia.10308","article-title":"Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury","volume":"45","author":"Tsuda","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.npep.2017.05.002_bb0150","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.npep.2017.05.002_bb0155","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuropharm.2015.12.026","article-title":"Increasing brain angiotensin converting enzyme 2 activity decreases anxiety-like behavior in male mice by activating central Mas receptors","volume":"105","author":"Wang","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2017.05.002_bb0160","doi-asserted-by":"crossref","first-page":"F579","DOI":"10.1152\/ajprenal.00548.2009","article-title":"Infusion of angiotensin-(1-7) reduces glomerulosclerosis through counteracting angiotensin II in experimental glomerulonephritis","volume":"298","author":"Zhang","year":"2010","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.npep.2017.05.002_bb0165","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.3892\/etm.2015.2801","article-title":"Chronic nerve injury-induced Mas receptor expression in dorsal root ganglion neurons alleviates neuropathic pain","volume":"10","author":"Zhao","year":"2015","journal-title":"Exp. Ther. Med."}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917300276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417917300276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:12:55Z","timestamp":1750273975000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417917300276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":33,"alternative-id":["S0143417917300276"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2017.05.002","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibitory effect of angiotensin (1-7) on angiotensin III-induced nociceptive behaviour in mice","name":"articletitle","label":"Article Title"},{"value":"Neuropeptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.npep.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}